Corona Remedies Ltd (CORONA)
·Next Day Close·+1.11%·₹2,076.75
Key EventTrading window closure announced for CORONA Remedies
Corona Remedies Ltd (CORONA)
·Next Day Close·+0.71%·₹2,214.3
Key EventInsiders sold shares under SEBI SAST Regulation 29(2)
Corona Remedies Ltd (CORONA)
·Next Day Close·+0.71%·₹2,214.3
Key EventSepia Investments Limited, Sage Investment Trust and Anchor Partners sold 2,630,880 shares of Corona Remedies Ltd
ImpactThe insiders sold a small portion of their stakes, reducing their ownership but maintaining significant holdings.Sign up to read impact
Corona Remedies Ltd (CORONA)
·Next Day Close·+0.71%·₹2,214.3
Key EventCompany schedules analyst/investor meeting for September 23, 2026
ImpactInvestors can engage directly with management on September 23, 2026 at 2:00 pm in Ahmedabad.Sign up to read impact
Corona Remedies Ltd (CORONA)
·Next Day Close·+1.64%·₹2,236.3
Key EventCompany clarifies volume movement is market-driven
ImpactShareholders should view volume spikes as normal market activity without hidden implications.Sign up to read impact
CORONA Remedies Limited (CORONA)
·Next Day Close·-1.14%·₹2,139.9
Key EventCompany confirms attendance at investor conference
ImpactShareholders should note the conference is purely informational with no UPSI discussed and schedule flexibility.Sign up to read impact
CORONA Remedies Limited (CORONA)
·Next Day Close·+1.05%·₹2,104.25
Key EventManagement reaffirmed FY27 growth targets and highlighted EU-GMP facility progress
ImpactThe company is on track to achieve 15% organic growth and 20% PAT growth in FY27, supported by chronic therapy expansion and new facility ramp-up.Sign up to read impact
CORONA Remedies Limited (CORONA)
·Next Day Close·+1.04%·₹2,082.35
Key EventBoard approves unaudited Q1 FY27 financial results with 30.1% YoY net profit growth
ImpactStrong top-line and bottom-line growth driven by core therapeutic expansion and new facility launch, though impacted by exceptional labour code costs.Sign up to read impact
CORONA Remedies Limited (CORONA)
·Next Day Close·+2.91%·₹2,166.6
Key EventAudio recording of Q1 FY27 earnings conference call made available
ImpactThe call recording provides direct access to management commentary on unaudited results.Sign up to read impact
CORONA Remedies Limited (CORONA)
·Next Day Close·-0.74%·₹2,027.4
Key EventCompany announces Q1 FY27 earnings conference call
ImpactInvestors can attend the call to hear management discuss Q1 FY27 results.Sign up to read impact